24 September 2025

The clinical efficacy and economic evaluation of EC-MPS (Myfortic®) in the treatment of relapse or resistant proliferative lupus nephritis. (in Thai language)

View Count

Share this research

Project Code 01-338-2552

Country

Thailand

Project Duration

Start : 1 January 2010

Research Status

Ongoing 65%

Complete Research Report

Quantity 2 files

Download Count

5 times

All research

24 September 2025

The clinical efficacy and economic evaluation of EC-MPS (Myfortic®) in the treatment of relapse or resistant proliferative lupus nephritis. (in Thai language)

About Project

Content

The Clinical Research Collaboration Network in collaboration with the HITAP conducted a clinical test of Randomized Controlled Trial (RCT) regarding the treatment of relapse or resistant proliferative lupus nephritis. The objective of this research was to determine the efficacy of enteric-coated Mycophenolate Sodium combined with corticosteroids for a period of 12 months in patients with relapse or cyclophosphamide-resistant proliferative lupus nephritis in the fourth criteria from renal biopsy, as well as to determine the economic evaluation of enteric-coated Mycophenolate Sodium compared to the treatment with standard intravenous cyclophosphamide in a health security perspective and a social perspective

Research Type

Others

Related Technologies

Pharmaceuticals

Funding Source

Faculty of Medicine, Chulalongkorn University

Thai Health Promotion Foundation (ThaiHealth)